Search research articles
Contact Us
Filters
Showing results (1-10 of 98) with videos related to
Page
of 10
Sort By:
Journal of Translational Medicine
|
May 29, 2004
Endothelin receptors as novel targets in tumor therapy
Anna Bagnato, Pier Giorgio Natali
The Journal of Biological Chemistry
|
June 5, 2003
Understanding human cancer using Drosophila: Tid47, a cytosolic product of the DnaJ-like tumor suppressor gene l2Tid, is a novel molecular partner of patched related to skin cancer
Itziar Canamasas, Anette Debes, Pier Giorgio Natali, et al.
Microorganisms
|
April 27, 2024
The Impact of Immune System Aging on Infectious Diseases
Eugenia Quiros-Roldan, Alessandra Sottini, Pier Giorgio Natali, et al.
Oncogene
|
July 12, 2005
Retinoblastoma protein acts as Pax 8 transcriptional coactivator
Stefania Miccadei, Claudia Provenzano, Martin Mojzisek, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 20, 2008
Identification of the minimal melanocyte-specific promoter in the melanocortin receptor 1 gene
Stefania Miccadei, Barbara Pascucci, Mauro Picardo, et al.
International Journal of Molecular Sciences
|
March 29, 2023
Improving Whole Tomato Transformation for Prostate Health: Benign Prostate Hypertrophy as an Exploratory Model
Pier Giorgio Natali, Mauro Piantelli, Marco Minacori, et al.
Oncogene
|
October 7, 2003
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels
Ester Fonsatti, Maresa Altomonte, Maria Rita Nicotra, et al.
The Journal of Biological Chemistry
|
September 7, 2004
Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion
Francesca Spinella, Laura Rosanò, Valeriana Di Castro, et al.
Journal of Cardiovascular Pharmacology
|
April 20, 2005
Therapeutic targeting of the endothelin-A receptor in human ovarian carcinoma: efficacy of cytotoxic agents is markedly enhanced by co-administration with atrasentan
Laura Rosanò, Francesca Spinella, Valeriana Di Castro, et al.
Molecular Endocrinology (Baltimore, Md.)
|
March 30, 2002
The synergistic activity of thyroid transcription factor 1 and Pax 8 relies on the promoter/enhancer interplay
Stefania Miccadei, Rossana De Leo, Enrico Zammarchi, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 98) with videos related to
Sort By:
Page
of 10
Journal of Translational Medicine
|
May 29, 2004
Endothelin receptors as novel targets in tumor therapy
Anna Bagnato, Pier Giorgio Natali
The Journal of Biological Chemistry
|
June 5, 2003
Understanding human cancer using Drosophila: Tid47, a cytosolic product of the DnaJ-like tumor suppressor gene l2Tid, is a novel molecular partner of patched related to skin cancer
Itziar Canamasas, Anette Debes, Pier Giorgio Natali, et al.
Microorganisms
|
April 27, 2024
The Impact of Immune System Aging on Infectious Diseases
Eugenia Quiros-Roldan, Alessandra Sottini, Pier Giorgio Natali, et al.
Oncogene
|
July 12, 2005
Retinoblastoma protein acts as Pax 8 transcriptional coactivator
Stefania Miccadei, Claudia Provenzano, Martin Mojzisek, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 20, 2008
Identification of the minimal melanocyte-specific promoter in the melanocortin receptor 1 gene
Stefania Miccadei, Barbara Pascucci, Mauro Picardo, et al.
International Journal of Molecular Sciences
|
March 29, 2023
Improving Whole Tomato Transformation for Prostate Health: Benign Prostate Hypertrophy as an Exploratory Model
Pier Giorgio Natali, Mauro Piantelli, Marco Minacori, et al.
Oncogene
|
October 7, 2003
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels
Ester Fonsatti, Maresa Altomonte, Maria Rita Nicotra, et al.
The Journal of Biological Chemistry
|
September 7, 2004
Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion
Francesca Spinella, Laura Rosanò, Valeriana Di Castro, et al.
Journal of Cardiovascular Pharmacology
|
April 20, 2005
Therapeutic targeting of the endothelin-A receptor in human ovarian carcinoma: efficacy of cytotoxic agents is markedly enhanced by co-administration with atrasentan
Laura Rosanò, Francesca Spinella, Valeriana Di Castro, et al.
Molecular Endocrinology (Baltimore, Md.)
|
March 30, 2002
The synergistic activity of thyroid transcription factor 1 and Pax 8 relies on the promoter/enhancer interplay
Stefania Miccadei, Rossana De Leo, Enrico Zammarchi, et al.
Page
of 10